Literature DB >> 31858807

Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention.

Qi Chen1, Hongzhen Bai1, Wangteng Wu1, Guojun Huang1, Yang Li1, Min Wu1, Guping Tang1, Yuan Ping2.   

Abstract

We herein propose a bioengineering approach where bacterial outer membrane vesicles (OMVs) were coated on drug-loaded polymeric micelles to generate an innovative nanomedicine for effective cancer immunotherapy and metastasis prevention. Whereas OMVs could activate the host immune response for cancer immunotherapy, the loaded drug within polymeric micelles would exert both chemotherapeutic and immunomodulatory roles to sensitize cancer cells to cytotoxic T lymphocytes (CTLs) and to kill cancer cells directly. We demonstrated that the systemic injection of such a bioinspired immunotherapeutic agent would not only provide effective protective immunity against melanoma occurrence but also significantly inhibited tumor growth in vivo and extended the survival rate of melanoma mice. Importantly, the nanomedicine could also effectively inhibit tumor metastasis to the lung. The bioinspired immunomodulatory nanomedicine we have developed repurposes the bacterial-based formulation for cancer immunotherapy, which also defines a useful bioengineering strategy to the improve current cancer immunotherapeutic agents and delivery systems.

Entities:  

Keywords:  Cancer therapy; Salmonella; bacterial outer membrane vesicle; biomimetic membrane coating; drug delivery; fluorouracil

Year:  2019        PMID: 31858807     DOI: 10.1021/acs.nanolett.9b02182

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  18 in total

Review 1.  Current Status and Future Directions of Bacteria-Based Immunotherapy.

Authors:  Quan Tang; Xian Peng; Bo Xu; Xuedong Zhou; Jing Chen; Lei Cheng
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 2.  Bacteria-Inspired Nanomedicine.

Authors:  Maya Holay; Zhongyuan Guo; Jessica Pihl; Jiyoung Heo; Joon Ho Park; Ronnie H Fang; Liangfang Zhang
Journal:  ACS Appl Bio Mater       Date:  2020-10-08

Review 3.  Bacteria-Based Cancer Immunotherapy.

Authors:  Xuehui Huang; Jingmei Pan; Funeng Xu; Binfen Shao; Yi Wang; Xing Guo; Shaobing Zhou
Journal:  Adv Sci (Weinh)       Date:  2021-02-10       Impact factor: 16.806

Review 4.  Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management.

Authors:  Khaled S Allemailem
Journal:  Int J Nanomedicine       Date:  2021-12-16

Review 5.  Nanotechnology-Employed Bacteria-Based Delivery Strategy for Enhanced Anticancer Therapy.

Authors:  Zixuan Ye; Lizhen Liang; Huazhen Lu; Yan Shen; Wenwu Zhou; Yanan Li
Journal:  Int J Nanomedicine       Date:  2021-12-14

Review 6.  Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope.

Authors:  Xinyu Lou; Zhichao Chen; Zhonggui He; Mengchi Sun; Jin Sun
Journal:  Nanomicro Lett       Date:  2021-01-04

Review 7.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12

Review 8.  Bacterial Outer Membrane Vesicles: From Discovery to Applications.

Authors:  Mariana G Sartorio; Evan J Pardue; Mario F Feldman; M Florencia Haurat
Journal:  Annu Rev Microbiol       Date:  2021-08-05       Impact factor: 16.232

9.  Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.

Authors:  Youqiong Ye; Xinwei Kuang; Zuozhong Xie; Long Liang; Zhao Zhang; Yongchang Zhang; Fangyu Ma; Qian Gao; Ruimin Chang; Heng-Huan Lee; Shuang Zhao; Juan Su; Hui Li; Jingbo Peng; Huifang Chen; Minzhu Yin; Cong Peng; Nong Yang; Jing Wang; Jing Liu; Hong Liu; Leng Han; Xiang Chen
Journal:  Genome Med       Date:  2020-09-28       Impact factor: 11.117

Review 10.  Recent Advances of Nanotechnology-Facilitated Bacteria-Based Drug and Gene Delivery Systems for Cancer Treatment.

Authors:  Chaojie Zhu; Zhiheng Ji; Junkai Ma; Zhijie Ding; Jie Shen; Qiwen Wang
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.